Center for Biotechnology and Genomic Medicine23


The Center for Biotechnology and Genomic Medicine's (CBGM) research efforts focus on two main areas: 1) discovery and validation of biomarkers for disease prediction and diagnosis, 2) pharmacomics and drug discovery for personalized medicine. CBGM is home of four internationally renowned programs in diabetes research: The Environmental Determinants of Diabetes in the Young (TEDDY), the Prospective Assessment in Newborns of Diabetes Autoimmunity (PANDA), the Diabetic Complications Consortium (DCC) and the Mouse Metabolic Phenotype Consortium (MMPC). Additional research programs include autoimmune diseases, transplantation, and cancer. These research programs are supported by an annual extramural funding of approximately $12 million.


Toolbar


Latest publications  RSS Feed

All items in the repository are protected by copyright; they may be used for educational purposes with proper attribution. All other uses require the author's permission.